Stock Detail
Videos
NeurAxis (NRXS) Company Webcast
NeurAxis, Inc. (NYSE American: NRXS) is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive...
NeurAxis (NRXS) Company Webcast
During this presentation, we welcome NeurAxis, ticker symbol NRXS on the NYSE American. Joining us today from the company is Brian Carrico, Chief Executive Officer. NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic...
News
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software. NeurAxis Inc. will begin the process of commercially marketing RED and expects initial...
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues
Conference call will be held today, Tuesday, November 12 at 9:00 am ETCARMEL, Ind., Nov. 12, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and...
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024
CARMEL, Ind., Nov. 05, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized...